Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3 or 4 in adults, children and infants

By Clements-Mann M.L.   Makhene M.K.   Mrukowicz J.   Wright P.F.   Hoshino Y.   Midthun K.   Sperber E.   Karron R.   Kapikian A.Z.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2715-2725

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

By Bernstein D.I.   Smith V.E.   Sherwood J.R.   Schiff G.M.   Sander D.S.   DeFeudis D.   Spriggs D.R.   Ward R.L.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 381-387

Elsevier

Access to resources Recommend Favorite

Generation and characterization of six single VP4 gene substitution reassortant rotavirus vaccine candidates: each bears a single human rotavirus VP4 gene encoding P serotype 1A[8] or 1B[4] and the remaining 10 genes of rhesus monkey rotavirus MMU18006 or bovine rotavirus UK

By Hoshino Y.   Jones R.W.   Chanock R.M.   Kapikian A.Z.  

Vaccine, Vol. 20, Iss. 29, 2002-10 ,pp. : 3576-3584

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers

By Kanesa-thasan N.   Sun W.   Kim-Ahn G.   Van Albert S.   Putnak J.R.   King A.   Raengsakulsrach B.   Christ-Schmidt H.   Gilson K.   Zahradnik J.M.   Vaughn D.W.   Innis B.L.   Saluzzo J.-F.   Hoke Jr C.H.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3179-3188

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme

By Piazza M.   Safary A.   Vegnente A.   Soncini R.   Pensati P.   Sardo M.   Orlando R.   Tosone G.   Picciotto L.  

Vaccine, Vol. 17, Iss. 6, 1999-02 ,pp. : 585-588

Elsevier

Access to resources Recommend Favorite